Company
Company

Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

ElevateBio

Main (gene editing) focus: Novel gene- and cell therapies

Company stage: Clinical

Diseases: Undisclosed

Genome editing tool: CRISPR-Cas, base editing, CRISPRa/CRISPRi

Funding stage: Private

Location: Cambridge, MA, USA

Website: https://www.elevate.bio/

Pipeline: https://www.elevate.bio/portfolio-pipeline

Partnerships: Life Edit Therapeutics (acquired)

ElevateBio is a gene- and cell therapy company. It is engaged in the genome-editing field through its acquisition of Life Edit Therapeutics that develops novel CRISPR-Cas, base editing and CRISPRa/CRISPRi systems. The company anticipates to integrate these novel gene-editing technologies with its existing iPSC, viral vector, and cell engineering platforms.

Tags

HashtagElevateBio

Company: ElevateBio
close
Search CRISPR Medicine